SKI Market

Indian Indices

Sensex

82,626.76 -1,048.16
( -1.25%)

Global Indices

Nasdaq

49,514.94 41.95
(0.08%)

Dow Jones

6,856.39 2.63
(0.04%)

Hang Seng

57,040.53 -599.31
(-1.04%)

Nikkei 225

10,448.94 46.50
(0.45%)

Forex

USD-INR

90.59 -0.07
(-0.07%)

EUR-INR

107.56 -0.26
(-0.24%)

GBP-INR

123.48 -0.32
(-0.26%)

JPY-INR

0.59 0.00
(0.20%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Beryl Drugs Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

524606

INE415H01017

18.6259045

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

11.13

EPS(TTM)

Face Value()

Div & Yield %

0.03

Back

manaksia ltd

Salora International reports standalone net loss of Rs 0.76 crore in the September 2025 quarter

Nov 14,2025

Net Loss of Salora International reported to Rs 0.76 crore in the quarter ended September 2025 as against net loss of Rs 0.41 crore during the previous quarter ended September 2024. Sales declined 75.50% to Rs 6.10 crore in the quarter ended September 2025 as against Rs 24.90 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	6.10	24.90	-76
OPM %	-10.82	-1.41	-
PBDT	-0.98	-0.53	-85
PBT	-1.04	-0.59	-76
NP	-0.76	-0.41	-85

82,626.76 -1,048.16 ( -1.25%)

49,514.94 41.95 (0.08%)

6,856.39 2.63 (0.04%)

57,040.53 -599.31 (-1.04%)

10,448.94 46.50 (0.45%)

90.59 -0.07 (-0.07%)

107.56 -0.26 (-0.24%)

123.48 -0.32 (-0.26%)

0.59 0.00 (0.20%)